08:48 AM EDT, 06/10/2024 (MT Newswires) -- Health care stocks were flat to lower premarket Monday, with the iShares Biotechnology ETF (IBB) inactive and the Health Care Select Sector SPDR Fund (XLV) down 0.3%.

Skye Bioscience ( SKYE ) shares were down more than 25% after the company said its phase 2a trial of SBI-100 ophthalmic emulsion to treat primary open-angle glaucoma or ocular hypertension did not meet its primary endpoint of lowering intraocular pressure.